Japan · Delayed Price · Currency is JPY SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 144.67 billion. The enterprise value is 144.06 billion.
| Market Cap | 144.67B |
| Enterprise Value | 144.06B |
Important Dates
The next estimated earnings date is Monday, March 16, 2026.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 78.03 million shares outstanding. The number of shares has increased by 4.89% in one year.
| Current Share Class | 78.03M |
| Shares Outstanding | 78.03M |
| Shares Change (YoY) | +4.89% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 24.87% |
| Owned by Institutions (%) | -2.36% |
| Float | 58.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 293.94 |
| P/TBV Ratio | 322.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -41.83 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 2.64.
| Current Ratio | 5.28 |
| Quick Ratio | 4.37 |
| Debt / Equity | 2.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -130.67 |
Financial Efficiency
Return on equity (ROE) is -621.25% and return on invested capital (ROIC) is -161.43%.
| Return on Equity (ROE) | -621.25% |
| Return on Assets (ROA) | -93.26% |
| Return on Invested Capital (ROIC) | -161.43% |
| Return on Capital Employed (ROCE) | -188.14% |
| Weighted Average Cost of Capital (WACC) | 4.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -118.77M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -728.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +141.72% in the last 52 weeks. The beta is -0.03, so SanBio Company's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | +141.72% |
| 50-Day Moving Average | 1,801.62 |
| 200-Day Moving Average | 2,437.27 |
| Relative Strength Index (RSI) | 49.50 |
| Average Volume (20 Days) | 1,114,985 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.71B |
| Pretax Income | -4.17B |
| Net Income | -3.44B |
| EBITDA | -3.70B |
| EBIT | -3.71B |
| Earnings Per Share (EPS) | -48.26 |
Balance Sheet
The company has 1.91 billion in cash and 1.30 billion in debt, with a net cash position of 608.31 million or 7.80 per share.
| Cash & Cash Equivalents | 1.91B |
| Total Debt | 1.30B |
| Net Cash | 608.31M |
| Net Cash Per Share | 7.80 |
| Equity (Book Value) | 492.19M |
| Book Value Per Share | 6.83 |
| Working Capital | 1.87B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.89% |
| Shareholder Yield | -4.89% |
| Earnings Yield | -2.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |